Status:
COMPLETED
Median Nerve Injury in US-guided Carpal Tunnel Injections
Lead Sponsor:
yi-chih HSU
Conditions:
Injury of Median Nerve Distal to Forearm
Carpal Tunnel Syndrome
Eligibility:
All Genders
20+ years
Brief Summary
Carpal tunnel syndrome (CTS) is the most common nerve compression disorder in the upper extremity. It can be treated with surgical or nonsurgical methods. When nonsurgical treatment is indicated, loca...
Detailed Description
Patients: This study was approved by our institutional review board (Tri-Service General Hospital); however, patient consent was not required for the retrospective review of records and images becaus...
Eligibility Criteria
Inclusion
- The clinical tests included (1) typical symptoms, eg, hand numbness and pain in the distribution of the median nerve, nocturnal worsening of symptoms, worsening symptoms while driving or gripping, (2) positive Tinel's and/or Phalen's sign, (3) failure of splinting and/or hand rest.
- Patients with clinically suspected CTS underwent US examination.
- The diagnoses of CTS in these patients were confirmed by US and/or electrodiagnostic investigations.
Exclusion
- prior carpal tunnel release
- loss of follow-up US examinations
- previous US-guided carpal tunnel injections
- US-guided carpal tunnel injections with recurrence on ipsilateral hands
Key Trial Info
Start Date :
February 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT03391336
Start Date
February 1 2017
End Date
December 1 2017
Last Update
January 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
No. 325, Sec. 2, Cheng-kung Rd., Neihu 114
Taipei, Taiwan, R.o.c., Taiwan, 886